Biotech is your new hobbyhorse alongside commodities 🙂
•
11
•
@NichtRelevant Yes, that is the case.
•
11
•@NichtRelevant However, I had already announced in my annual outlook at the end of last year that I see these two sectors as the most promising in 2026
•
11
•@Multibagger I also find biotech very exciting, but with start-ups and smaller companies in particular, a lot often depends on one or two potential product developments and the associated studies. You have to stay on the ball - it's not something you can blindly leave lying around for a long time.
Ultimately, however, it's not a bad thing if you're speculating and are prepared to invest time in research.
For me - where I am not informed on a daily basis - I am instead betting on the big 'buyers' in this area, at the moment $PFE (Pfizer) and $AMGN (Amgen).
Ultimately, however, it's not a bad thing if you're speculating and are prepared to invest time in research.
For me - where I am not informed on a daily basis - I am instead betting on the big 'buyers' in this area, at the moment $PFE (Pfizer) and $AMGN (Amgen).
•
11
•@NichtRelevant That's right, that's why I sold $GPCR and $NKTR after the sharp rises and am now only buying them again via a savings plan in my Biotech Pie at Trading 212. And I currently have around 15 biotech stocks in my portfolio. It is unlikely that they will all fail.
••